RT @ShelleyMLM: The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts fo…

We now have FOUR potential clinical trials open at @MDAndersonNews for patients with small cell/large cell/neuroendocrine cervical cancer. Both targeted and immunotherapies. Excited to offer so many opportunities to patients with this rare cancer @SARCC @LaurenByersMD

RT @IJGConline: Clinicopathologic characteristics, oncologic outcomes & prognostic factors in #neuroendocrine #CervicalCarcinoma #NECTURstu…

RT @danahazime1: Honored to receive the Felix Rutledge Society travel award and excited to be presenting my research at this year’s annual…

RT @Elsevier_Med: “This is likely the most comprehensive book for these rare gynecological cancers.” -©Doody’s Review Service, 2023. Read f…

RT @ShelleyMLM: The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce "Rhonda's Award 2023" is now open. We will accept submi…

RT @Elsevier_Med: “Both the physical textbook and the ebook achieve this goal and provide guidance from workup to primary treatment to recu…

RT @leitaomd: Diagnosis and Treatment of Rare Gynecologic Cancers #Amazon

RT @BethGarciaMDA: Patient Experience rounds are back @MDAndersonNews with @Frumovitz CPXO. Outstanding work going on in Head and Neck Cent…

@cgmd33 @pedroramirezMD Was it just one slide that said “It doesn’t work”?

So excited to be at the @Allyson4Rare gala in support of young people with cancer. So appreciative of their amazing support of our #NECC research. @MDAndersonNews @SCCCLCCCSisters

RT @ShelleyMLM: The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce Dr. Kylie Gorringe as the recipient of Rhonda's Award.…

RT @ShelleyMLM: The deadline to apply for up to $50,000 to fund research on mucinous ovarian cancer is July 14th. Find details about Rhonda…

$50K Rhonda’s Award to support research in mucinous ovarian cancer now being offered by the Mucinous Ovarian Cancer Coalition/MOCC. Details/deadlines here: Great opportunity for research in this #raretumor @SGO_org @ESGO_society @IGCSociety @ShelleyMLM

RT @katiekurnit: Excited to share a new research award for mucinous ovarian cancer! Application now open, deadline on 6/2. Can’t wait to ma…

RT @ShelleyMLM: We are the Mucinous Ovarian Cancer Coalition. Launched by my late sister in September of 2020. In addition to financial sup…

Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at @MDAndersonNews opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! @SGO_org @NANETS1 @SCCCLCCCSisters @ShannonWestin @karenluMD

Stay tuned! Our trial with AK104 (cadonilimab), a bispecific PD1/CTLA4 antibody, for women with neuroendocrine cervical cancer should open next week! So close!! @SCCCLCCCSisters @SGO_org @NANETS1

RT @AshAlexander44: Health care providers, join us tonight’s Physician Advisory Council meeting, where we will be joined by MD Anderson Pre…

@SKS1377 @MDAndersonNews @zivanovicmd @JennyMueller_ @ShelleyMLM @katiekurnit @AnilSoodMD This trial is open to patients from outside the US although it may not be covered by your insurance like it likely will be for women with US insurance